Stock AKBA AKEBIA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Akebia Therapeutics, Inc.

Equities

AKBA

US00972D1054

Market Closed - Nasdaq
Other stock markets
 21:00:00 14/05/2024 BST 		5-day change 1st Jan Change
1.23 USD -4.65% Intraday chart for Akebia Therapeutics, Inc. -12.14% -0.81%
05-09 Transcript : Akebia Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024
05-09 Earnings Flash (AKBA) AKEBIA THERAPEUTICS Reports Q1 Revenue $32.6M MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
AKEBIA THERAPEUTICS, INC. Stock Akebia Therapeutics, Inc.
 258M - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 111B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 22.24B -
ARGENX SE Stock argenx SE
 21.25B -
GENMAB A/S Stock Genmab A/S
 18.97B
  1. Stock Market
  2. Equities
  3. AKBA Stock
  4. Charts Akebia Therapeutics, Inc.
  5. Sector Chart